Olujimi Odusanya is a pharmacist who is specialized in Ambulatory Care in Bowie, Maryland. Patients can reach him at 8904 Elm Ave, Bowie or contact him on 301-802-8024. Active license number of Olujimi Odusanya is 15737 for Ambulatory Care in Maryland. Olujimi Odusanya is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Olujimi Odusanya speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Olujimi Odusanya
Specialization:
Ambulatory Care
Gender:
Male
Location:
8904 Elm Ave, Bowie, Maryland, 20720-3612
Phone:
301-802-8024
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Olujimi Odusanya are as mentioned below.
NPI Number:
1295394153
NPI Enumeration Date:
13 Jun, 2019
NPI Last Update On:
13 Jun, 2019
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Olujimi Odusanya are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
15737
Maryland
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
8904 Elm Ave, Bowie, Maryland
Zip:
20720-3612
Phone Number:
--
Fax Number:
--
Patients can reach Olujimi Odusanya at 8904 Elm Ave, Bowie, Maryland or can call on phone at 301-802-8024.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.